Target intelligence / Profile preview

Pantetheine pathway enzyme

Molecular classification
Enzyme, Kinase, Synthetase, Decarboxylase, Transferase
01

Overview

Pantetheine pathway enzymes are a group of enzymes vital to the biosynthesis of coenzyme A (CoA) from pantothenic acid (vitamin B5). This pathway involves phosphorylation, condensation with cysteine, decarboxylation, adenylylation, and final phosphorylation, each catalyzed by a distinct enzyme. These enzymes are essential for the formation of CoA, which is a cofactor in hundreds of metabolic reactions, especially in energy metabolism, fatty acid synthesis, and carboxylic acid activation. Due to the differences in the biosynthetic pathway between microbes and humans, several of these enzymes are attractive targets for antimicrobial drug development. However, "Pantetheine pathway enzyme" is a non-specific descriptor and should be clarified to refer to a specific enzyme in this pathway for precise scientific communication[1][2][3][5][6].

Other names
Pantothenate kinasePanKPhosphopantothenoylcysteine synthetasePPC decarboxylasePhosphopantetheine adenylyl transferasePPATDephosphocoenzyme A kinase
02

Mechanism of action

Competitive or allosteric inhibition of enzyme activity (e.g., blocking substrate binding or mimicking regulatory feedback, as CoA is a feedback inhibitor)[2][3]

03

Biological functions

Coenzyme A biosynthesisFatty acid synthesisEnergy metabolismAcyl/acetyl group transferProsthetic group synthesis for acyl carrier protein (ACP)
04

Disease associations

Infection (antimicrobial drug target)Metabolic disorders (pantothenate kinase deficiency, e.g. PKAN)Neurodegeneration (in context of PKAN)
05

Safety considerations

Targeting microbial enzymes offers selectivity, but off-target effects or toxicity may arise if similar enzymes are inhibited in human cells.Pantothenate kinase in humans is essential; deficiency leads to PKAN, a neurodegenerative disease[6]
06

Interacting drugs

Experimental antibiotics (some designed to inhibit PanK and related CoA pathway enzymes in bacteria and fungi)[2]
07

Biomarkers

Reduced CoA levelsaccumulation of metabolic intermediates (such as 4'-phosphopantetheine)functional assays of enzyme activities

Beyond the preview

Go deeper on Pantetheine pathway enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pantetheine pathway enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call